NEK9 (1-979), (fragment supprimé 346-731), active, GST étiqueté humain, PRECISIO Kinase, recombinant, exprimé en cellules baculovirus infectées Sf9, >=70% (SDS-PAGE), solution de glycérol aqueuse tamponnée

Code: srp5053-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

NEK9 is a member of the NEK family and has high homology to NEK1, NEK3 and NEK4. NEK9 is activated during mitosis and binds specifically to RAN GTPase and...


en savoir plus

Votre prix
$566.47 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

NEK9 is a member of the NEK family and has high homology to NEK1, NEK3 and NEK4. NEK9 is activated during mitosis and binds specifically to RAN GTPase and is a substrate for CDC2 phosphorylation. NEK9 plays a role in the control of mitotic progression and is regulated by CDC2 and RAN GTPase. Overexpression of both active and inactive variants of NEK9 is toxic to cells and inhibits cell division causing abnormal nuclear morphologies. NEK9 can catalyze the phosphorylation of recombinant NEK6 and NEK7 in vitro leading to its activation. This suggests that NEK9 may be responsible for activation of NEK6 and NEK7 during mitosis.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.

Preparation Note

after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... NEK9(91754)
mol wt~115 kDa
NCBI accession no.NM_033116
product linePRECISIO® Kinase
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity102-138 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: